News

Director Joanna M. Burkey filed a Form 4 with the SEC on August 10, 2026, reporting the acquisition of a non-qualified stock option on CorVel Corp common stock dated August 6, 2026.

Target Hospitality Corp. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting a net loss for both the three- and six-month periods ended on that date.

Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) has revealed promising preclinical findings showing that its compound, Telomir-Zn, significantly suppresses tumor growth in several cancer models, including prostate cancer and triple-negative breast cancer (TNBC). Comparatively, the company's earnings per share of $-0.28 missed the $-0.07 consensus estimate …

Quanterix (Nasdaq: QTRX) posted second‑quarter revenue of $32.9 million, a 34% jump from the $24.5 million recorded a year earlier, while earnings per share registered a loss of $‑0.45 against a consensus expectation of $‑0.47. The company ended the quarter with $96.9 million in …

Investors are weighing the earnings shortfall against a strong rally and a 12% short‑interest position that implies modest pressure to cover. The contrast between the negative EPS and the market’s bullish price action underscores theVolatilityinherent in biotech valuations.

Jazz Pharmaceuticals (Nasdaq: JAZZ) announced an $820 million upfrontAcquisitionof Actio Biosciences, with an additional $500 million possible contingent payout. The transaction adds ABS‑1230, a KCNT1 ion‑channel inhibitor, to the company’s rare epilepsyFranchise. The deal deepens Jazz’s pipeline as it seeks to diversify beyond its …

Microbot Medical Inc. (Nasdaq: MBOT), a company specializing in robotic medical devices, has announced a new material agreement. This key development indicates a significant strategic move designed to strengthen the company’s operational capabilities and market positioning within the competitive healthcare technology sector. The agreement …